Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Increased risk for liver cirrhosis death among Hispanic Americans

Risk of liver cirrhosis mortality is increased among white Hispanic Americans, finds a National Institute on Alcohol Abuse and Alcoholism analysis of data from 1997.

News image

fiogf49gjkf04

This was the first year that all the American states included Hispanic origin on death certificates.

Cirrhosis death rates were found to be highest among white Hispanic males, followed by black non-Hispanic males, white non-Hispanic males, white Hispanic females, black non-Hispanic females, and white non-Hispanic females.

Most of the 1997 white Hispanic decedents were of Mexican ancestry. Many were born outside the United States and had low education levels.

Reported in Alcoholism: Clinical and Experimental Research, the findings have immediate implications for research and health practice, and potential impact on health policy directions.

"The new Hispanic ethnicity distinction on certificates of death corrects the decades-old belief that black males are at greatest risk of cirrhosis death. Clinicians should be newly alert to the risk for white Hispanic males," said NIAAA Deputy Director Mary Dufour, one of the study authors.

"This dramatic finding from 1997 warrants close re-examination as data for subsequent years become available," said Dr Dufour.

Increased liver cirrhosis deaths may be due to drinking patterns among Hispanics.
Alcoholism: Clinical and Experimental Research
"In addition, NIAAA will examine cirrhosis mortality by state to identify any possible influences of environment and point up implications for health services delivery."

In 1989, the US Standard Certificate of Death was revised to include Hispanic origin of the decedent. This allowed for the study of racial/ethnic groups, such as white Hispanic, white non-Hispanic, black Hispanic, and black non-Hispanic. These designations accounted for 96% of the US population during the 1990s, according to lead study author Frederick S. Stinson.

"Rates of cirrhosis death remain high among black non-Hispanic men and women, but are considerably higher among white Hispanic men and women.

"Our results demonstrate the importance of the Hispanic designation in epidemiologic research, but complicate the search to explain the observed differences among racial and ethnic groups," Dr. Stinson said.

Increased risk for liver cirrhosis deaths among white Hispanic males may be explained by different drinking patterns among population subgroups or other factors.

Some Hispanic groups, especially those of Mexican and Central American heritage, have a drinking style marked by the periodic consumption of large amounts of alcohol. Other candidate factors include socioeconomic status and its component dimensions of income, occupation, and poverty status, all of which directly affect the use of medical care services.

"Doctors and other health care workers need to be aware of the increased risk of cirrhosis death in white Hispanic males in order to advise them of risks that seem to be associated with specific drinking patterns," comments Bridget F. Grant, NIAAA Biometry Branch Chief.

National Institute on Alcohol Abuse and Alcoholism
20 August 2001

Go to top of page Email this page Email this page to a colleague

 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us